SRC/YES1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,977 results for “SRC/YES1”

Trials

View all 2160 →

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

12 participants · First posted Nov 30, 2011

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

30 participants · First posted Sep 7, 2018

Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction

22 participants · First posted Jun 14, 2021

Drugs

View all 445 →

Src-40-49-Tat

SRC-2 antagonists

15a(SRC inhibitors)

Organizations

View all 155 →

PRC TICINUM LAB SRL

Italy

YES Pharmaceutical Development Services GmbH

Germany

SRM Entertainment

United States

News

View all 217 →

Nuvectis Pharma Initiates Phase 1b Combination Study of NXP900 with Osimertinib for Resistant EGFR-Mutated NSCLC

Nuvectis Pharma to Present Promising NXP900 Data at 2025 AACR Meeting

Nuvectis Pharma Reports Financial Results and Highlights Clinical Progress of NXP800 and NXP900

Page 1 of 298